Are Gian Lifecare latest results good or bad?
Gian Lifecare's latest results show mixed performance: net sales declined by 21.62%, but net profit increased by 108.33%, indicating improved profitability despite sales challenges. The operating profit margin slightly decreased, while interest expenses were reduced, suggesting effective cost management.
Gian Lifecare has reported its financial results for the quarter ending June 2025, with a summary indicating flat financial performance compared to previous quarters. The company experienced a net sales decline of 21.62% in this quarter, which is an improvement from a more significant decline of 30.19% in the previous quarter. On the other hand, Gian Lifecare's consolidated net profit showed a notable increase of 108.33%, a significant turnaround from a decline of 271.43% in the prior quarter. This suggests that while sales faced challenges, the company managed to enhance its profitability significantly.
The operating profit margin, excluding other income, was reported at 16.99%, reflecting a slight decrease from the previous quarter's margin of 16.09%. Additionally, interest expenses saw a decline of 30.77%, indicating potential cost management efforts.
Overall, the company saw an adjustment in its evaluation, which may prompt stakeholders to consider the implications of these financial results on its operational effectiveness and market position within the healthcare services sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
